body { background: #06080c; color: #e5e9f0; margin: 0; } .rw-nojs-bar { max-width: 880px; margin: 0 auto; padding: 18px 16px 14px; } .rw-nojs-bar .rw-nojs-brand { font: 700 20px/1 Inter, system-ui, sans-serif; color: #e5e9f0; text-decoration: none; } .rw-nojs-nav { max-width: 880px; margin: 0 auto; padding: 0 16px 14px; border-bottom: 1px solid #1c2230; font: 500 14px/1.4 Inter, system-ui, sans-serif; } .rw-nojs-nav a { color: #6f9bff; margin: 0 14px 6px 0; text-decoration: none; display: inline-block; } .rw-nojs-nav a:hover { text-decoration: underline; } .rw-nojs-note { max-width: 880px; margin: 12px auto 0; padding: 0 16px; font: 400 13px/1.5 Inter, system-ui, sans-serif; color: #8a93a6; } #root [data-rw-crawler] { max-width: 880px; margin: 0 auto; padding: 8px 16px 48px; font: 400 16px/1.65 Inter, system-ui, sans-serif; color: #e5e9f0; } #root [data-rw-crawler] a { color: #6f9bff; } #root [data-rw-crawler] h1 { font-size: 28px; line-height: 1.2; } #root [data-rw-crawler] h2 { font-size: 20px; margin-top: 28px; } #root [data-rw-crawler] img { max-width: 100%; height: auto; } #root [data-rw-crawler] ul { padding-left: 0; list-style: none; } #root [data-rw-crawler] li { margin: 0 0 18px; } #root [data-rw-crawler] .rw-pagination { margin: 28px 0 0; display: flex; flex-wrap: wrap; gap: 12px; align-items: baseline; } #root [data-rw-crawler] .rw-pagination strong { color: #e5e9f0; } .rw-nojs-footer { max-width: 880px; margin: 40px auto 0; padding: 22px 16px 44px; border-top: 1px solid #1c2230; font: 400 13px/1.6 Inter, system-ui, sans-serif; color: #8a93a6; } .rw-nojs-footer .rw-nojs-fcols { display: flex; flex-wrap: wrap; gap: 28px 40px; margin-bottom: 20px; } .rw-nojs-footer h2 { font-size: 11px; letter-spacing: 0.05em; text-transform: uppercase; color: #b7c0d3; margin: 0 0 8px; } .rw-nojs-footer a { color: #6f9bff; text-decoration: none; display: block; margin: 0 0 5px; } .rw-nojs-footer a:hover { text-decoration: underline; } .rw-nojs-footer .rw-nojs-legal { font: 400 12px/1.6 Inter, system-ui, sans-serif; color: #6b7384; margin: 0; } .rw-nojs-footer .rw-nojs-legal a { display: inline; } RuntimeWire Investigations Stories AI Startups Venture Products Funding Exits Models Head-to-Head About You're browsing RuntimeWire with JavaScript disabled. Articles and navigation work fully. Interactive features — search, comments, and newsletter signup — require JavaScript.

Takeda's $600 Million Insilico Deal Puts Alex Zhavoronkov's AI Platform Deeper Into Big Pharma

The proposed pact gives Takeda worldwide rights to AI-discovered drug candidates while leaving most of the economics tied to milestones.

By Ryan Merket · Published Jul 1st, 2026, 7:09pm CT

Detailed vintage scientific illustration of an ornate microscope and chemical glassware, subtly interwoven with mechanical gears and molecular structures (Vintage scientific plate, engraved style)

The proposed pact gives Takeda worldwide rights to AI-discovered drug candidates while leaving most of the economics tied to milestones.

Sections

Investigations Stories AI Startups Venture Products Funding Exits

Publication

About FAQ Contact Editorial Policy Corrections Policy Ethics

Tools

AI Model Pricing Head-to-Head

Legal

Privacy Terms

© 2026 RuntimeWire, Inc. All rights reserved.
An independent startup and technology publication based in Austin, Texas and San Francisco, California. Send tips to tips@runtimewire.com.